1. Home
  2. RDY vs WD Comparison

RDY vs WD Comparison

Compare RDY & WD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • WD
  • Stock Information
  • Founded
  • RDY 1984
  • WD 1937
  • Country
  • RDY India
  • WD United States
  • Employees
  • RDY N/A
  • WD N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • WD Finance: Consumer Services
  • Sector
  • RDY Health Care
  • WD Finance
  • Exchange
  • RDY Nasdaq
  • WD Nasdaq
  • Market Cap
  • RDY 2.1B
  • WD 2.4B
  • IPO Year
  • RDY N/A
  • WD 2010
  • Fundamental
  • Price
  • RDY $14.53
  • WD $75.72
  • Analyst Decision
  • RDY Strong Buy
  • WD Hold
  • Analyst Count
  • RDY 2
  • WD 3
  • Target Price
  • RDY $16.95
  • WD $103.33
  • AVG Volume (30 Days)
  • RDY 1.5M
  • WD 337.6K
  • Earning Date
  • RDY 07-28-2025
  • WD 08-07-2025
  • Dividend Yield
  • RDY 0.56%
  • WD 3.54%
  • EPS Growth
  • RDY 1.47
  • WD 6.51
  • EPS
  • RDY 0.79
  • WD 2.92
  • Revenue
  • RDY $3,809,801,863.00
  • WD $1,056,015,000.00
  • Revenue This Year
  • RDY $10.24
  • WD $14.45
  • Revenue Next Year
  • RDY N/A
  • WD $6.64
  • P/E Ratio
  • RDY $18.39
  • WD $25.96
  • Revenue Growth
  • RDY 16.61
  • WD 8.64
  • 52 Week Low
  • RDY $12.26
  • WD $64.48
  • 52 Week High
  • RDY $16.89
  • WD $118.19
  • Technical
  • Relative Strength Index (RSI)
  • RDY 37.98
  • WD 62.33
  • Support Level
  • RDY $14.81
  • WD $71.81
  • Resistance Level
  • RDY $15.25
  • WD $76.89
  • Average True Range (ATR)
  • RDY 0.20
  • WD 2.07
  • MACD
  • RDY -0.12
  • WD 0.70
  • Stochastic Oscillator
  • RDY 5.18
  • WD 88.94

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About WD Walker & Dunlop Inc

Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.

Share on Social Networks: